« Return to News | Drug Sponsors | CROs/Service Providers

Vyteris moves into clinical research with MediSync merger

Thursday, April 21, 2011 12:19 PM

U.S.-based drug delivery specialist Vyteris hopes to gain revenue and operational efficiency by entering into the contract research sector, according to Pharma Times.

Vyteris merged with MediSync Biosciences, which focuses on acquiring and consolidating high-value, niche CROs, SMOs and related businesses such as post-marketing surveillance companies.

According to Vyteris’ Form 10-K annual report for 2010,  these opportunities include a signed letter of intent with a service management organization specializing in trials requiring a controlled environment; and negotiations with a CRO running a 50-bed research unit, an “international CRO,” and a research company specializing in post-marketing surveillance.

Vyteris’ new CRO business model is expected “to provide cash flow which can assist in funding operations while we continue to develop our drug delivery technologies,” the Form 10-K says. “It will also provide operational synergies as two business operations are combined in one infrastructure, creating efficiencies in administrative functions as well as other areas.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.